Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of HIV-1 transmitted drug resistance in the incarcerated population.

HIV medicine - 1 Nov 2017

Sapozhnikov J, Young J D, Patel M, Chiampas T D, Vaughn P, Badowski M E

Abstract excerpt

OBJECTIVES: The aim of the study was to determine the prevalence of transmitted drug resistance (TDR)-associated mutations among treatment-naïve, incarcerated individuals with HIV-1 infection in the USA as well as the class TDR and antiretroviral (ARV) mutations present at baseline. METHODS: Patients over the age of 18 years were included in the study if they had been diagnosed with HIV infection, if their HIV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Transmission, Infectious
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Prevalence

Share to Prisoners

Share to United States

Share to Young Adult

Source

Identifiers

PMID: 28585361
DOI: 10.1111/hiv.12522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of HIV-1 transmitted drug resistance in the incarcerated population.PMID 28585361Read ↗

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.Semantic proximity Read ↗

[Prevalence of transmitted drug resistance in HIV-infected treatment-naive patients in Chile].Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Semantic proximity Read ↗

Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DCSemantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.Semantic proximity Read ↗

HIV drug resistance following a decade of the free antiretroviral therapy programme in India: A review.Semantic proximity Read ↗

Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative surveySemantic proximity Read ↗

New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.